멸균 튜브 용접기 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the sterile tubing welder market size is expected to grow from USD 2.79 billion in 2025 to USD 2.94 billion in 2026 and is forecast to reach USD 3.82 billion by 2031 at 5.39% CAGR over 2026-2031.

This report is Segmented by Tube Material (TPE, PVC, and More), Mode (Automatic and Manual), Application (Blood Processing, Biopharmaceutical Manufacturing, and More), End-User (Hospitals and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Sterile Tubing Welder Market Trends and Insights

Rising Adoption of Single-Use Bioprocessing

Single-use assemblies already support more than 1.2 million sterile connections per year, according to Sartorius. Eliminating cross-contamination between batches can trim facility capital outlays by up to 40%, encouraging large commercial plants to integrate disposables alongside legacy stainless downstream trains. More robust connectors that comply with the ASME BPE code now anchor these systems, satisfying auditor concerns over integrity. As regulatory bodies have endorsed disposables within EU GMP Annex 1, plant managers are expanding inventories of flexible tubing and calling for welders capable of handling TPE, silicone, and multilayer films in fast changeovers. This dynamic secures a durable growth path for the sterile tubing welder market while reinforcing automation investment to close remaining contamination gaps.

Expanding Biologics & Cell-Gene Therapy Pipelines

Cell and gene therapy batches require up to 10 times more sterile connections than legacy small-molecule processing, a reality now shaping equipment budgets across the sterile tubing welder market. Singapore's investment in mRNA cancer vaccines and South Korea's USD 1.92 billion allocation for home-grown mRNA platforms underscore regional appetite for advanced modality capacity. Portable, modular factories such as MIT's InSCyT system highlight how distributed production demands compact welders that can validate hundreds of connections per shift. As regulators draft guidance on decentralized manufacturing, suppliers able to ensure sterility in small-footprint devices will capture share. Continuous activity in novel vectors and personalized immunotherapies sustains elevated connection volumes, pushing the sterile tubing welder market toward higher-throughput, auto-calibrating equipment.

High Capital & Validation Cost of Automated Welders

A fully qualified welding skid can exceed USD 100,000 and accrues another 30-50% in validation labor. Smaller CDMOs in Latin America and Southeast Asia often postpone purchases, favoring outsourced batch preparation where the welder is already installed. The sterile tubing welder market thus experiences elongated sales cycles in emerging regions. Vendors are piloting equipment-as-a-service contracts that spread payments over multi-year terms, and some offer pre-validated "smart welders" bundled with digital IQ/OQ templates to curb consultant fees.

Other drivers and restraints analyzed in the detailed report include:

1. Growth in Global Blood & Plasma Collections
2. Stricter cGMP Sterility Regulations
3. Availability of Sterile Connector Alternatives

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

TPE tubing captured 48.02% of the sterile tubing welder market share in 2025 and is expanding at a 5.55% CAGR, reflecting pharmaceutical preference for low-extractable, gamma-compatible materials. This leadership locks in large volumes for welders configured specifically for TPE melt temperatures, broadening the sterile tubing welder market size derived from TPE lines alone. PVC persists in budget-focused blood centers, while silicone finds narrow roles where elevated temperatures or solvents demand it.

Manufacturers such as Teknor Apex are launching clear, ultra-low-spallation grades that allow optical inspection during welding. KRAIBURG's PFAS-free advances future-proof supply amid tightening chemical restrictions, reinforcing TPE's pull on capital budgets. Meanwhile, force-majeure events have pushed end-users to qualify multiple TPE brands to secure continuity, prompting welder firmware updates that store unique heat profiles for each compound.

Automatic units owned 62.10% of the sterile tubing welder market size in 2025 and show the highest 5.51% CAGR, a twin-lead gained by eliminating human contact and standardizing weld quality. Their batch-record integration supports real-time release criteria, a factor especially valued in EU inspections. Because of that compliance edge, automatic platforms are the reference specification for every new commercial bioreactor suite, cementing the sterile tubing welder market size advantage over manual units.

First-generation bench welders required expert setup, yet modern models calibrate themselves through barcode-driven tubing IDs, cutting training hours. Inline sensors measure weld pressure and temperature, feeding data to manufacturing execution systems that trigger preventive maintenance. Manual devices remain in R&D cabinets where flexibility matters, but they now compete on price alone as automatic prices fall.

Complete Report Scope:

• By Tube Material
  • Thermoplastic Elastomer (TPE)
  • PVC
  • Silicone
  • Others
• By Mode
  • Automatic
  • Manual
• By Application
  • Blood Processing
  • Biopharmaceutical Manufacturing
  • Diagnostic Laboratories
  • Others
• By End-User
  • Hospitals
  • Research & Academic Institutes
  • Contract Manufacturing
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 38.12% of the sterile tubing welder market revenue in 2025, propelled by its dense biopharma corridor, historic uptake of single-use technology, and a regulatory culture that rewards advanced contamination controls. Thermo Fisher Scientific's USD 2 billion multi-year capacity investment amplifies the regional order book, while Danaher's Cytiva-Pall consolidation broadens a service backbone that accelerates validation. Vendor training academies in Boston and San Diego also mitigate operator shortages, sustaining utilization rates across installed fleets.

Asia-Pacific is the fastest-growing territory at 6.07% CAGR through 2031. China's USD 4.17 billion biomanufacturing incentive, Samsung Biologics' 784,000 L build-out, and Singapore's mRNA programs are channeling record equipment imports. Regional governments have also streamlined GMP licensing, removing one historical hurdle to automated welding adoption. While skill gaps remain acute, suppliers have localized after-sales hubs in Shanghai, Seoul, and Hyderabad to provide on-site validation.

Europe maintains steady expansion under hard-line sterility rules. Annex 1 revisions oblige legacy plants to retrofit welders into Grade A cleanrooms, inflating replacement demand. The continent additionally benefits from aggressive cell-therapy pipelines in France and the United Kingdom, spawning many small clinical-scale units that collectively lift volume. In emerging regions-Latin America, the Middle East, and Africa-market momentum stems from public blood-bank upgrades and new vaccine fill-finish lines, though funding cycles stretch project timelines.

1. Aseptic Group
2. Avantor
3. ChargePoint Technology
4. Colder Products Company (CPC)
5. Danaher
6. Entegris
7. Genesis BPS
8. GMPTEC GmbH
9. Hangzhou Cobetter Filtration Equipment Co., Ltd
10. Meissner Filtration Products
11. MGA Technologies
12. Parker Hannifin
13. PendoTECH
14. Repligen
15. Saint-Gobain Life Sciences
16. Sartorius
17. Terumo
18. Thermo Fisher Scientific
19. Vante Biopharm/Sebra
20. Watson-Marlow Fluid Technology

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising adoption of single-use bioprocessing
  • 4.2.2 Expanding biologics & cell-gene therapy pipelines
  • 4.2.3 Growth in global blood & plasma collections
  • 4.2.4 Stricter cGMP sterility regulations
  • 4.2.5 Decentralized point-of-care manufacturing push
  • 4.2.6 Multi-use aseptic connectors lowering validation cost
• 4.3 Market Restraints
  • 4.3.1 High capital & validation cost of automated welders
  • 4.3.2 Availability of sterile connector alternatives
  • 4.3.3 Shortage of skilled operators / training gaps
  • 4.3.4 TPE-grade supply chain volatility
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Tube Material
  • 5.1.1 Thermoplastic Elastomer (TPE)
  • 5.1.2 PVC
  • 5.1.3 Silicone
  • 5.1.4 Others
• 5.2 By Mode
  • 5.2.1 Automatic
  • 5.2.2 Manual
• 5.3 By Application
  • 5.3.1 Blood Processing
  • 5.3.2 Biopharmaceutical Manufacturing
  • 5.3.3 Diagnostic Laboratories
  • 5.3.4 Others
• 5.4 By End-User
  • 5.4.1 Hospitals
  • 5.4.2 Research & Academic Institutes
  • 5.4.3 Contract Manufacturing
  • 5.4.4 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Competitive Benchmarking
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.4.1 Aseptic Group
  • 6.4.2 Avantor, Inc.
  • 6.4.3 ChargePoint Technology
  • 6.4.4 Colder Products Company (CPC)
  • 6.4.5 Danaher Corporation
  • 6.4.6 Entegris, Inc.
  • 6.4.7 Genesis BPS
  • 6.4.8 GMPTEC GmbH
  • 6.4.9 Hangzhou Cobetter Filtration Equipment Co., Ltd
  • 6.4.10 Meissner Filtration Products
  • 6.4.11 MGA Technologies
  • 6.4.12 Parker-Hannifin Corporation
  • 6.4.13 PendoTECH
  • 6.4.14 Repligen Corporation
  • 6.4.15 Saint-Gobain Life Sciences
  • 6.4.16 Sartorius AG
  • 6.4.17 Terumo Corporation
  • 6.4.18 Thermo Fisher Scientific
  • 6.4.19 Vante Biopharm/Sebra
  • 6.4.20 Watson-Marlow Fluid Technology

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment